Our objective was to compare the effect of a long-acting calcium antagonist (nisoldipine) versus an ACE inhibitor (lisinopril) on albuminuria, arterial blood pressure, and glomerular filtration rate (GFR) in hypertensive IDDM patients with diabetic nephropathy. We performed a 1-year, double-blind, doubledummy, randomized, controlled study comparing nisoldipine (20–40 mg once daily) with lisinopril (10–20 mg once daily) in 52 hypertensive IDDM subjects with diabetic nephropathy. Three patients dropped out, and results for the remaining 49 (25 nisoldipine, 24 lisinopril) are presented. Diuretics were required in 10 nisoldipineand 8 lisinopril-treated patients. Every 3 months, 24-h ambulatory blood pressure (TM2420, A&D, Tokyo, Japan) and albuminuria in three 24-h samples (enzyme immunoassay) were measured; GFR (51Cr-EDTA plasma clearance) was recorded every 6 months. Mean arterial blood pressure (24 h) was reduced from (mean ± SE) 108 ± 3 mmHg at baseline to 101 ± 2 in average during treatment in the lisinopril group and from 105 ± 2 to 103 ± 2 in the nisoldipine group (P = 0.06 comparing changes in the two groups). Albuminuria was reduced 47% (95% CI 21–65) in the lisinopril group versus an increase of 11% (−3 to 27) in the nisoldipine group (P = 0.001). Fractional albumin clearance was reduced 37% (95% CI 4–59%) in the lisinopril versus an increase of 35% (8–69%) in the nisoldipine group (P < 0.01). GFR decreased from 85 ± 5 ml · min−1 · 1.73 m−2 to 73 ± 5 in the lisinopril group and from 84 ± 6 to 80 ± 7 in the nisoldipine group (P < 0.05). The effect of study medication on albuminuria and GFR was independent of changes in systemic blood pressure and baseline variables in multiple regression analyses. In summary, lisinopril reduced albuminuria, but also GFR, to a greater extent than did nisoldipine in hypertensive IDDM patients with diabetic nephropathy during the 1st year of treatment. Longer follow-up is required to clarify whether these drugs have different renoprotective effects.
Skip Nav Destination
Article navigation
Original Articles|
March 01 1997
Differences Between Nisoldipine and Lisinopril on Glomerular Filtration Rates and Albuminuria in Hypertensive IDDM Patients With Diabetic Nephropathy During the First Year of Treatment
Peter Rossing;
Peter Rossing
Steno Diabetes Center
Gentofte, Denmark
Search for other works by this author on:
Lise Tarnow;
Lise Tarnow
Steno Diabetes Center
Gentofte, Denmark
Search for other works by this author on:
Søren Boelskifte;
Søren Boelskifte
Steno Diabetes Center
Gentofte, Denmark
Search for other works by this author on:
Berit R Jensen;
Berit R Jensen
Steno Diabetes Center
Gentofte, Denmark
Search for other works by this author on:
Flemming S Nielsen;
Flemming S Nielsen
Steno Diabetes Center
Gentofte, Denmark
Search for other works by this author on:
Hans-Henrik Parving
Hans-Henrik Parving
Steno Diabetes Center
Gentofte, Denmark
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Peter Rossing, Steno Diabetes Center, 2 Niels Steensens Vej, DK-2820 Gentofte, Denmark. [email protected].
1
CC, coat core; GFR, glomerular filtration rate; θAlb, fractional clearance of albumin; θIgG, fractional clearance of IgG.
Diabetes 1997;46(3):481–487
Article history
Received:
May 24 1996
Revision Received:
October 17 1996
Accepted:
October 17 1996
PubMed:
9032106
Citation
Peter Rossing, Lise Tarnow, Søren Boelskifte, Berit R Jensen, Flemming S Nielsen, Hans-Henrik Parving; Differences Between Nisoldipine and Lisinopril on Glomerular Filtration Rates and Albuminuria in Hypertensive IDDM Patients With Diabetic Nephropathy During the First Year of Treatment. Diabetes 1 March 1997; 46 (3): 481–487. https://doi.org/10.2337/diab.46.3.481
Download citation file:
106
Views